Huatai Pb Fund Management Co Ltd - Huatai-PineBridge Hang Seng Biotechnology ETF (SHA:513930)

Assets	n/a
Expense Ratio	n/a
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	n/a

Volume	71,701,800
Open	1.096
Previous Close	1.095
Day's Range	1.092 - 1.111
52-Week Low	0.789
52-Week High	1.120
Beta	n/a
Holdings	32
Inception Date	Mar 9, 2026

About 513930

513930.SS was created on 2026-03-09 by Huatai. The fund's investment portfolio concentrates primarily on health care equity. Closely track the performance of the underlying index, aiming to minimize tracking deviation and tracking error.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 513930
• Provider: Huatai
• Index Tracked: Hang Seng Biotechnology Index - CNY - Benchmark TR Gross

Top 10 Holdings

77.51% of assets

Name	Symbol	Weight
Cash	n/a	10.60%
BeOne Medicines AG	6160	10.27%
Innovent Biologics, Inc.	1801	10.25%
WuXi Biologics (Cayman) Inc.	2269	10.01%
WuXi AppTec Co., Ltd.	2359	8.51%
Akeso, Inc.	9926	7.31%
CSPC Pharmaceutical Group Limited	1093	6.41%
Sino Biopharmaceutical Limited	1177	5.19%
Hansoh Pharmaceutical Group Company Limited	3692	5.06%
3SBio Inc.	1530	3.91%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error